Our professionals can help to navigate through a wide range of industry segments, including patent drug producers and generic manufacturers, suppliers of medical and diagnostic equipment, life sciences companies, distributors and pharmacy chains, R&D institutions and industry associations
Experts say that the industry is shifting to a new operational model known as “personalised pharmaceuticals”. While R&D remains crucial to a company's success in the marketplace, CEOs of pharmaceutical companies have other pressing issues to address. These include controlling compliance with international and national regulations, developing an effective supply chain, enhancing marketing quality and improving the global management model for pharmaceutical businesses.
And although the Ukrainian pharmaceutical market shares the same concerns, it also must deal with a number of country-specific features and issues. Ukraine must still improve conditions for the development of both Ukrainian and foreign producers.
PwC specialists offer a range of services to help pharmaceutical companies improve the efficiency of their supply chain and distribution, protect intellectual property rights, tackle the issues of certification and licensing, and comply with the complex organisational, tax and legal requirements for clinical research.
We are ready to help you find effective solutions to the challenges of attracting and targeting investments, as well to provide support regarding various other issues on the road to success in the Ukrainian market.
Advisory leader, PwC Ukraine
Tel: +380 44 354 0404